Forbion
VC
INVESTOR TYPE
Active
STATUS
11
PROFESSIONALS
130
INVESTMENTS
21
PORTFOLIO
60
EXITS
Description
Forbion is an investment firm that prefers to invest in the healthcare, life sciences, oncology and manufacturing sectors. The firm was established in 2006 and is based in Naarden, Netherlands.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2006
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
- PO Box 5187
- 1410 AD Naarden
- Netherlands
+31 035 000 0000
Forbion Investments (130)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Dyne Therapeutics | 03-Apr-2019 | Early Stage VC | 0000 | Pharmaceuticals | Generating Revenue | 0000 0000000 |
| 000000000 | 19-Nov-2018 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 0000000 00.0 |
| 0000000 0000000000 | 02-Nov-2018 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 1 | 000000 0000000000 00.0 |
| 000000000 00000000 | 25-Oct-2018 | 00000 00000 | 0000 | Pharmaceuticals | Clinical Trials - Phase 3 | 00000 0000000 00.0 |
| 000000 00000000000 | 10-Oct-2018 | 00000 00000 | 0000 | Drug Discovery | Startup | 000000 0000000000 00.0 |
| 00000 000000000000 | 29-Aug-2018 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 00000-000 000000 00 |
| 0000000000 0000000 | 12-Apr-2018 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | 00000-000 000000 00 |
| 00000000 000000000 | 04-Apr-2018 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 00000 0000000 00.0 |
| NorthSea Therapeutics | 12-Dec-2017 | Early Stage VC | 000.00 | Biotechnology | Clinical Trials - Phase 3 | 000000 00000000 |
| Hookipa Pharma | 11-Dec-2017 | Later Stage VC | 000.00 | Biotechnology | Generating Revenue/Not Profitable | 000000 000 00000000 00.0 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Forbion’s full profile, request a free trial.
Forbion Exits (60)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals | 13-May-2019 | IPO | 000.00 | Completed |
|
| 0000000 000000 | 18-Apr-2019 | 000 | 0000 | Completed |
|
| 00000 000000000000 | 30-Nov-2018 | 0000000000: 000000 | Completed |
|
|
| 0000000 | 31-Aug-2018 | 000000000 00000000 | Completed |
|
|
| 0000000 0000000000 | 01-Aug-2018 | 000000000000000000 | 00000 | Completed |
|
| 000000000 | 20-Jul-2018 | 000 | 00000 | Completed |
|
| 0000000 0000000000 | 16-Mar-2018 | 000000000000000000 | 00.000 | Completed |
|
| 00000000 | 26-Oct-2017 | 000000000000000000 | 00000 | Completed |
|
| Argenx | 18-May-2017 | Public Investment 2nd Offering | 00000 | Completed |
|
| uniQure | 31-Mar-2017 | Secondary Transaction - Open Market | Completed |
|
Forbion Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore Forbion‘s full profile, request access.
Request full access to PitchBookForbion Team (30)
6 Former Team Members
You’re viewing 5 of 30 team members. Get the full list »Forbion Co-Investors (81)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| New Science Ventures | 4 | 0 | 0 |
| Andera Partners | 0 | 0 | |
| BioGeneration Ventures | 0 | 0 | |
| Novartis Venture Fund | 0 | 0 | |
| Novo Holdings | 0 | 0 |